RxDoctor Payments Data

Shaun Hill

Optometrist · Springfield, ILNPI 1790886521

Payments from drug & device makers

$1,191in general payments, 2019–2025

Across 23 payments — averaging $51.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$710
  • Johnson & Johnson Vision Care, Inc.$168
  • Biotissue Holdings Inc.$108
  • Shire North American Group Inc$76
  • Bausch & Lomb Americas Inc.$45
  • Johnson & Johnson Surgical Vision, Inc.$38
  • plus $45 from 2 others

What the payments were for

  • Consulting fees$756%
  • Speaking & faculty fees$66656%
  • Food & beverage$42335%
  • Entertainment$282%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,191 in reported general payments places this provider in the 65th percentile of 2,257 optometrist providers in Illinois.

See all optometrist providers in Illinois

Medicare billing

Part B allowed, 2024
$90,916
Medicare patients
620
Services billed
1,871

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost56$31,234
RestasisCyclosporine24$22,441
XiidraLifitegrast16$17,928
Cyclosporine26$10,821
Travoprost54$8,966
IyuzehLatanoprost/Pf13$3,916
Latanoprost309$2,479
Brimonidine Tartrate47$1,758
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol11$1,655
Tobramycin-DexamethasoneTobramycin/Dexamethasone25$941
Prednisolone Acetate22$779
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat26$439
Timolol Maleate53$377
Levobunolol Hcl14$218
Dorzolamide Hcl19$111

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bausch & Lomb Americas Inc.Xiidra$45$17,92816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,257 optometrist providers in Illinois.

Other optometrist in Springfield

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →